サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1654727

世界の鼓膜切開用製品市場-2025-2033年

Global Tympanostomy Products Market - 2025-2033

出版日
ページ情報
英文 176 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.03円
世界の鼓膜切開用製品市場-2025-2033年
出版日: 2025年02月13日
発行: DataM Intelligence
ページ情報: 英文 176 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の鼓膜切開用製品市場は、2024年に9,876万米ドルに達し、2033年には1億3,276万米ドルに達すると予測され、予測期間2025年にはCAGR 3.37%で成長すると予測されています。

鼓膜切開術は、慢性的な耳の感染症や中耳に溜まった液体を治療するために一般的に用いられる医療処置であり、多くの場合小児に用いられます。この処置では、鼓膜に小さな切開を加えて液体を排出し、換気チューブまたはイヤーチューブとして知られる小さなチューブを挿入して中耳の換気を保ちます。これにより、さらに液体がたまるのを防ぎ、感染症の再発のリスクを減らし、圧迫感や痛みから解放されます。

鼓膜切開用製品市場には、シリコン、チタン、グロメットなどの素材で作られた様々なタイプの通気チューブなど、処置に使用される様々な製品が含まれます。その他の主要製品には、切開を行うための手術器具、感染を防ぐための局所抗生物質、患者の快適性を高める麻酔などがあります。

市場力学：

促進要因と抑制要因

耳感染症の増加

特に小児における耳感染症の増加が、鼓膜切開用製品市場を大きく押し上げると予想されます。耳の感染症は幼児によく見られる問題であり、繰り返し発症すると体液の蓄積や難聴などの合併症を引き起こす可能性があります。例えば、2024年の米国国立衛生研究所の報告によると、慢性化膿性中耳炎（OM）の世界の発症率は1,000人当たり4.76人で、約3,100万件に相当すると報告されています。このうち、22.6％は5歳未満の小児で毎年発症しています。このような感染症が頻繁に起こるようになるにつれ、長期的な問題を予防し、聴力を回復させる鼓膜切開術の需要が高まっています。この処置では、鼓膜に小さな通気チューブを挿入することで、耳の排水を良くし、将来の感染を防ぎます。

鼓膜切開チューブやその他の関連製品を必要とする子供たちが増えているため、これらの機器の市場は拡大する傾向にあります。未治療の耳感染症が長期的な影響を及ぼす可能性についての認識が高まるにつれ、効果的な治療法の必要性はさらに高まっています。さらに、医療技術の進歩に伴い、より侵襲性の低い新しい人工呼吸チューブが開発され、患者の予後を改善し、市場のさらなる成長を促しています。この動向は、特に幼児の耳感染症が依然として多いことから、今後も続くと予想されます。

開発途上地域における認知度の低さ

新興国では認知度が低いため、患者や医療従事者が処置のメリットを認識できず、鼓膜切開用製品市場の成長を妨げる可能性があります。多くの低所得地域では、子どもの難聴や発達の遅れを防ぐといった長期的なメリットに関する知識が不足している可能性があります。このため、市場全体の成長に影響を与える、より効果の低い治療法が使用される可能性があります。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 耳の感染症の発生率上昇
    • 抑制要因
      • 発展途上地域での認識の低さ
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 特許分析
  • 規制分析
  • SWOT分析
  • アンメットニーズ

第6章 製品タイプ別

  • 鼓室チューブ
  • チューブアプリケーター/インサーター
  • その他

第7章 素材の種類別

  • チタン
  • フッ素樹脂
  • シリコーン
  • ステンレス鋼
  • その他

第8章 用途別

  • 慢性中耳炎
  • 再発性急性中耳炎
  • 耳管機能障害
  • その他

第9章 最終用途別

  • 病院
  • 外来手術センター
  • 専門クリニック
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州地域
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 中東・アフリカ

第11章 競合情勢

  • 競合シナリオ
  • 市況・シェア分析
  • M&A分析

第12章 企業プロファイル

  • Atos Medical AB
    • 会社概要
    • 製品ポートフォリオ
      • 製品説明
      • 製品の主要業績評価指標（KPI）
      • 過去および予測の製品販売
      • 製品販売量
    • 財務概要
      • 会社の収益
      • 地域別収益分配
      • 収益予測
    • 主な発展
      • 合併と買収
      • 主な製品開発活動
      • 規制当局の承認等
    • SWOT分析
  • Preceptis Medical
  • Smith+Nephew
  • Medasil Surgical Limited
  • Cape Medical Group
  • SPIGGLE & THEIS Medizintechnik GmbH
  • Bryan Medical Inc.
  • EON Meditech
  • Grace Medical
  • Summit Medical LLC.

第13章 付録

目次
Product Code: PH8431

The global tympanostomy products market reached US$ 98.76 million in 2024 and is expected to reach US$ 132.76 million by 2033, growing at a CAGR of 3.37% during the forecast period 2025-2033.

Tympanostomy is a medical procedure commonly used to treat chronic ear infections and fluid buildup in the middle ear, often in children. During the procedure, a small incision is made in the eardrum to allow for the drainage of fluid and to insert a small tube, known as a ventilation tube or ear tube, to keep the middle ear ventilated. This helps prevent further fluid accumulation and reduces the risk of recurrent infections, providing relief from pressure and pain.

The Tympanostomy products market includes various products used in the procedure, such as different types of ventilation tubes made from materials like silicone, titanium, and grommets. Other key products include surgical instruments for performing the incision, topical antibiotics to prevent infection, and anesthesia for patient comfort.

Market Dynamics: Drivers & Restraints

Rising Incidence of Ear Infections

The rising number of ear infections, particularly in children, is expected to significantly boost the Tympanostomy products market. Ear infections are a common problem in young children, and when they occur repeatedly, they can lead to complications like fluid buildup and even hearing loss. For instance, according to the report by the National Institute of Health in 2024, the global incidence of chronic suppurative otitis media (OM) is reported to be 4.76 per thousand, equating to approximately 31 million cases. Of these, 22.6% occur annually in children under the age of five. As these infections become more frequent, the demand for Tympanostomy procedures, which help prevent long-term issues and restore hearing, is growing. During this procedure, small ventilation tubes are inserted into the eardrum to allow the ear to drain properly and avoid future infections.

With more children needing Tympanostomy tubes and other related products, the market for these devices is set to expand. As awareness grows about the potential long-term effects of untreated ear infection the need for effective treatments becomes even more critical. Furthermore, as medical technology advances, new, less invasive ventilation tubes are being developed, improving patient outcomes and driving further growth in the market. This trend is expected to continue, especially as ear infections remain prevalent in young children.

Limited Awareness in Developing Regions

Limited awareness in developing regions can hinder the growth of the Tympanostomy products market by preventing patients and healthcare providers from recognizing the benefits of the procedure. In many low-income areas, there may be a lack of knowledge about the long-term advantages, such as preventing hearing loss and developmental delays in children. This can lead to the use of less effective treatments affecting the overall market growth.

Segment Analysis

The global tympanostomy products market is segmented based on product type, material type, application, end user, and region.

Product Type:

Tympanostomy tubes segment is expected to dominate the global tympanostomy products market share

The Tympanostomy tubes segment is expected to dominate the global Tympanostomy products market due to their essential role in the treatment of chronic ear infections and fluid buildup in the middle ear. These small, medical-grade tubes are inserted into the eardrum during a Tympanostomy procedure to help ventilate the ear and prevent future infections. As the most commonly used product in the procedure, Tympanostomy tubes are in high demand, especially among children who are more prone to recurrent ear infections.

The growing incidence of ear infections and the increasing awareness of the long-term effects of untreated conditions, such as hearing loss or speech delays, are driving this demand. Additionally, advances in tube design and materials are making these tubes more effective and easier to use, leading to greater adoption among healthcare professionals.

With continuous improvements in technology and a larger patient population in need of these tubes, the Tympanostomy tubes segment is expected to maintain its dominant position in the global market. For instance, in March 2024, Innovia Medical has expanded their range of ENT Vent Tubes to the UK and EU markets.

Geographical Analysis

North America is expected to hold a significant position in the global tympanostomy products market share

North America is expected to maintain a strong position in the global tympanostomy products market due to a combination of high demand and advanced healthcare infrastructure. The region sees a high prevalence of ear infections, particularly among children, which drives the need for tympanostomy procedures to address chronic issues and prevent long-term complications like hearing loss. For instance, By the time they reach 3 years old, over 80% of children will have experienced at least one ear infection. In the United States, ear infections are responsible for approximately 30 million visits to paediatricians annually. As more children are diagnosed with frequent ear infections, the demand for tympanostomy tubes and related products is steadily increasing.

Moreover, North America's healthcare system is well-equipped with cutting-edge technologies, including state-of-the-art surgical instruments and advanced ventilation tubes that improve the effectiveness of the procedure. The region also benefits from a strong focus on early intervention, with paediatricians frequently recommending Tympanostomy to prevent the developmental impacts of untreated ear infections, such as speech delays.

Furthermore, ongoing research and development in North America continue to drive innovation in Tympanostomy tube design, making them more effective, durable, and minimally invasive. Companies in the regions are expanding their availability across various regions. For instance, in December 2023, Preceptis Medical, Inc. announced that children will have expanded access to the Hummingbird in-office ear tube procedure through a collaboration with one of the largest Medicaid payers in the United States. These factors, combined with favourable insurance coverage and access to healthcare, ensure that North America will continue to lead the global Tympanostomy products market.

Competitive Landscape

The major global players in the tympanostomy products market include Atos Medical AB, Preceptis Medical, Smith+Nephew, Medasil Surgical Limited, Cape Medical Group, SPIGGLE & THEIS Medizintechnik GmbH, Bryan Medical Inc., EON Meditech, Grace Medical and Summit Medical LLC. among others.

Key Developments

  • In August 2024, AventaMed, a KARL STORZ company, has received U.S. Food and Drug Administration 510(k) clearance for its Solo+ ear-tube placement device. The Solo+ device integrates several steps into a single tool, offering a more streamlined approach for performing office-based tympanostomies.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Global Tympanostomy Products Market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Material Type
  • 3.3. Snippet by Application
  • 3.4. Snippet by End User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Incidence of Ear Infections
    • 4.1.2. Restraints
      • 4.1.2.1. Limited Awareness in Developing Regions
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Patent Analysis
  • 5.5. Regulatory Analysis
  • 5.6. SWOT Analysis
  • 5.7. Unmet Needs

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Tympanostomy Tubes*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Tube Applicators / Inserters
  • 6.4. Others

7. By Material Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 7.1.2. Market Attractiveness Index, By Material Type
  • 7.2. Titanium*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Fluoroplastic
  • 7.4. Silicone
  • 7.5. Stainless Steel
  • 7.6. Others

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Chronic Otitis Media*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Recurrent Acute Otitis Media
  • 8.4. Eustachian Tube Dysfunction
  • 8.5. Others

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Ambulatory Surgical Centers
  • 9.4. Specialty Clinics
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.7.1. U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Spain
      • 10.3.7.5. Italy
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. South Korea
      • 10.5.7.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

Key Market Players

  • 12.1. Atos Medical AB*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio
      • 12.1.2.1. Product Description
      • 12.1.2.2. Product Key Performance Indicators (KPIs)
      • 12.1.2.3. Historic and Forecasted Product Sales
      • 12.1.2.4. Product Sales Volume
    • 12.1.3. Financial Overview
      • 12.1.3.1. Company Revenue's
      • 12.1.3.2. Geographical Revenue Shares
      • 12.1.3.3. Revenue Forecasts
    • 12.1.4. Key Developments
      • 12.1.4.1. Mergers & Acquisitions
      • 12.1.4.2. Key Product Development Activities
      • 12.1.4.3. Regulatory Approvals etc.
    • 12.1.5. SWOT Analysis
  • 12.2. Preceptis Medical
  • 12.3. Smith+Nephew
  • 12.4. Medasil Surgical Limited
  • 12.5. Cape Medical Group
  • 12.6. SPIGGLE & THEIS Medizintechnik GmbH
  • 12.7. Bryan Medical Inc.
  • 12.8. EON Meditech
  • 12.9. Grace Medical
  • 12.10. Summit Medical LLC.

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us